Vaccine-Induced Antibodies that Neutralize Group 1 and Group 2 Influenza A Viruses - Wikidata - wikimedia - TriplyDB

Vaccine-Induced Antibodies that Neutralize Group 1 and Group 2 Influenza A Viruses

Vaccine-Induced Antibodies that Neutralize Group 1 and Group 2 Influenza A Viruses

http://www.wikidata.org/entity/Q27644544

about

Influenza What Are the Most Powerful Immunogen Design Vaccine Strategies?Human Monoclonal Antibody 81.39a Effectively Neutralizes Emerging Influenza A Viruses of Group 1 and 2 Hemagglutinins An Influenza HA and M2e Based Vaccine Delivered by a Novel Attenuated Salmonella Mutant Protects Mice against Homologous H1N1 Infection.Different Repeat Annual Influenza Vaccinations Improve the Antibody Response to Drifted Influenza Strains Antibodyomics: bioinformatics technologies for understanding B-cell immunity to HIV-1.Rapid profiling of RSV antibody repertoires from the memory B cells of naturally infected adult donors A Broadly Reactive Human Anti-hemagglutinin Stem Monoclonal Antibody That Inhibits Influenza A Virus Particle Release.Preferential induction of cross-group influenza A hemagglutinin stem-specific memory B cells after H7N9 immunization in humans.Novel in vitro booster vaccination to rapidly generate antigen-specific human monoclonal antibodies.The Individual and Population Genetics of Antibody Immunity.Tfh cells and HIV bnAbs, an immunodominance model of the HIV neutralizing antibody generation problem.Immunization-Elicited Broadly Protective Antibody Reveals Ebolavirus Fusion Loop as a Site of Vulnerability.From Original Antigenic Sin to the Universal Influenza Virus Vaccine.Advances in Vaccines to Prevent Viral Respiratory Illnesses in Children.Antibody 27F3 Broadly Targets Influenza A Group 1 and 2 Hemagglutinins through a Further Variation in VH1-69 Antibody Orientation on the HA Stem.Vaccine approaches conferring cross-protection against influenza viruses.Functional interrogation and mining of natively paired human VH:VL antibody repertoires.Passive immunotherapy of viral infections: 'super-antibodies' enter the fray.Memory B Cells that Cross-React with Group 1 and Group 2 Influenza A Viruses Are Abundant in Adult Human Repertoires.Emerging viral diseases from a vaccinology perspective: preparing for the next pandemic.Structural insights into the design of novel anti-influenza therapies.Insights into the Structural Basis of Antibody Affinity Maturation from Next-Generation Sequencing.IL-15 enhances cross-reactive antibody recall responses to seasonal H3 influenza viruses in vitro.An Antibody Targeting the Fusion Machinery Neutralizes Dual-Tropic Infection and Defines a Site of Vulnerability on Epstein-Barr Virus.A public antibody lineage that potently inhibits malaria infection through dual binding to the circumsporozoite protein.Use of Hemagglutinin Stem Probes Demonstrate Prevalence of Broadly Reactive Group 1 Influenza Antibodies in Human Sera.How single mutations affect viral escape from broad and narrow antibodies to H1 influenza hemagglutinin.Development of a high-throughput assay to detect antibody inhibition of low pH induced conformational changes of influenza virus hemagglutinin.Structural analysis of influenza vaccine virus-like particles reveals a multicomponent organization.Characterization of Hemagglutinin Antigens on Influenza Virus and within Vaccines Using Electron Microscopy.One-step CRISPR/Cas9 method for the rapid generation of human antibody heavy chain knock-in mice Tracing Antibody Repertoire Evolution by Systems Phylogeny Antibody Cross-Reactivity in Antivenom Research Complementary recognition of the receptor-binding site of highly pathogenic H5N1 influenza viruses by two human neutralizing antibodies Beyond Hot Spots: Biases in Antibody Somatic Hypermutation and Implications for Vaccine Design Influenza, evolution, and the next pandemic

P2860

Q28066188-3E24C3D7-36D3-4B71-9545-4970C9943E54 Q28729792-2C8401FD-73BF-48D4-BAF9-44015C345632 Q30392944-552F20D9-B357-4F21-B1CD-72F048F67C5D Q33679360-7D2E3B46-79DF-48F2-B16A-29025FA489FB Q33899438-34C952F7-95C6-430E-BB2B-ABA0C16F3398 Q36263513-84F29C81-E162-4C92-82FE-588E4FCD4F8A Q37593886-6395AECA-1163-41A5-B990-FCBE6C0C618B Q37714300-9B0245B1-5BEC-4205-8AE9-26A16B869825 Q38636861-11A2F04B-630B-4CCD-AD52-BF0F9416432C Q38652483-E53653C4-308C-4798-8255-7B1497F02DF1 Q38766578-035895DF-DB82-4516-A54E-DB271F968F86 Q39108730-872887F8-4BB8-4545-AAC8-303E93FA51DA Q40056179-B4C7CF48-C5D7-4F85-A8AB-3F7F086F0EF2 Q40059787-3BBCB6F5-9D74-4402-A946-1E60BD3C40EE Q40082914-E8446F55-9E4D-4DF5-9FB8-460F9AC9336F Q41933744-FA172782-7724-456C-A48A-68323B3E19C8 Q41934895-B1180E19-854C-4DD8-B493-25374279F9E0 Q47194745-1E42C4C5-9BE1-4AAC-84A4-1A454BB39DCB Q47548101-740BB7AB-2FCD-4351-8E52-0A0EF949CD4F Q47552319-F9D88D81-34AD-4117-9837-37E83390DA45 Q47570091-92FC3044-2B48-451C-A5F3-F3BB7EE9ABDC Q48113181-6F1A48E7-D8D8-4A83-BE26-0F4DFF93D061 Q49956907-179BA8CD-5541-485D-974B-90B8A42D4217 Q50534689-A38CD878-BD02-4EB8-BAB7-D7404E172644 Q52317335-29B14654-61B1-4CF4-95B5-7BEE30C6DF5C Q53700367-7018E90C-9FB4-4CA1-8B59-5F0FD104F8EF Q55312137-F5B3D3F1-0C53-4146-A016-7A345069D844 Q55318229-1D64CBC6-BA10-4F95-B096-68801E2EE9A2 Q55501368-37998146-8224-49A3-B4AC-1B30712B20C9 Q55627667-AA10E17B-F1AE-4F47-9BE3-F055BB41DFBC Q55689231-3806F475-C192-4882-8190-F4DFC2AE82CA Q57157197-64484E49-E58A-4B52-9B48-C4ED45C5D6ED Q58586481-7DE0928E-1ABC-4678-93C0-BE8C15F1A28D Q58646919-FC667C0D-4EC6-408F-8DEA-A2564DA9701D Q58696897-7A38E634-C36E-4BA5-B64B-795EB899443B Q58781552-A58D031B-C3A9-4F57-9A0D-B1EDB9316307 Q59136752-EECD27DA-12FA-415F-BB25-3212B5764194

P2860

Vaccine-Induced Antibodies that Neutralize Group 1 and Group 2 Influenza A Viruses

http://www.wikidata.org/entity/Q27644544

description

2016 nî lūn-bûn

@nan

2016 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

name

Vaccine-Induced Antibodies that Neutralize Group 1 and Group 2 Influenza A Viruses

@ast

Vaccine-Induced Antibodies that Neutralize Group 1 and Group 2 Influenza A Viruses

@en

Vaccine-Induced Antibodies that Neutralize Group 1 and Group 2 Influenza A Viruses

@nl

type

label

Vaccine-Induced Antibodies that Neutralize Group 1 and Group 2 Influenza A Viruses

@ast

Vaccine-Induced Antibodies that Neutralize Group 1 and Group 2 Influenza A Viruses

@en

Vaccine-Induced Antibodies that Neutralize Group 1 and Group 2 Influenza A Viruses

@nl

prefLabel

Vaccine-Induced Antibodies that Neutralize Group 1 and Group 2 Influenza A Viruses

@ast

Vaccine-Induced Antibodies that Neutralize Group 1 and Group 2 Influenza A Viruses

@en

Vaccine-Induced Antibodies that Neutralize Group 1 and Group 2 Influenza A Viruses

@nl

P1433

Q27644544-F806FD79-5D07-4030-850E-BB8FA2E3218F

P1476

Q27644544-4FBC556F-6A8A-446B-832C-645129D7AFA4

P2093

Q27644544-03249542-8BCF-4A3E-9C85-BF155E444F49

Q27644544-042EBC94-CAB5-44D3-A921-52D44492ED3A

Q27644544-1776609A-FC7E-4133-A53A-60DAF1669DEB

Q27644544-221C7A1F-A5B4-41F0-B745-436BEFFE4AC6

Q27644544-31D31DFD-D567-496F-8ED4-B153BB54E0C8

Q27644544-33B1D5DB-B9FB-4CD2-949C-435710ACEF65

Q27644544-379FD606-BE44-49F3-BF0C-B430DFE05F5F

Q27644544-3834B04D-BFC9-445B-B5CF-7BE9467A9F0F

Q27644544-39B65269-92CE-42A6-B6B1-26D89A708D9A

Q27644544-3DA42765-C766-49B8-A2BC-9D052C31E5A6

P2860

Q27644544-11335D72-7724-4D62-9E05-5ED918683376

Q27644544-1C8EC1D2-9CF3-4152-988A-ACAE753E14F7

Q27644544-29331AEB-7371-4CF2-9C4D-E0E72BE69C13

Q27644544-2A5C50CB-9C46-44C2-8078-5F78A4424617

Q27644544-2F2CDF4A-9C5D-46F5-ABE8-B429A3A0D44E

Q27644544-32BDF854-D273-40A8-AECE-C749F6C17449

Q27644544-34295482-87C9-4636-B90E-C8C8283812BE

Q27644544-3A70D94E-5057-4CFE-AB9E-2E40E90F9972

Q27644544-3D42B335-F754-407A-9174-0BBE74227AB8

Q27644544-43E94274-DE5A-4818-A8BF-4024BD012FFA

P304

Q27644544-C28968A0-9B91-4942-BB92-5AE74A8D25D1

P31

Q27644544-680B027E-738C-4DD9-AF40-AF19DE0B9F17

P3181

Q27644544-3794FB2B-59A9-4B7B-8AF8-B749EAC153CF

P356

Q27644544-5FD88502-B8D8-4FAF-9E99-0FD28DF69F4B

P407

Q27644544-3A9AB750-F42E-4C67-B401-0876A66C5969

P433

Q27644544-EF9E53EE-5E6C-4C26-A37B-F5237F4F908A

P478

Q27644544-02CE46CF-9B5D-4084-9756-18CAAF04AE79

P50

Q27644544-36D5C6C4-8A84-4701-AC4B-9176CF720387

Q27644544-3D4DDC85-CBFC-4B13-A388-B0A5275B7DF2

Q27644544-549114DF-2F48-4767-B9EF-7B58D318D22B

Q27644544-581BB803-015C-4714-A775-96DAE412D70E

Q27644544-735D5F04-A229-454D-950C-C7CFD6F85F7F

Q27644544-8304C598-E042-4705-922A-7E0C0F46AEE5

Q27644544-B551F73C-A031-442B-8271-B11E6CC4F1CD

Q27644544-C859B4DD-6E7B-4335-9A81-2AC22AB753AE

Q27644544-E127327F-18DC-49C1-8914-6C2AF192A01B

Q27644544-F8CC95E1-5CA8-419D-948F-5F64A10F25A0

P577

Q27644544-746D981A-AA3A-41E9-B5AA-6E8FF08548FB

P698

Q27644544-21CEBAF2-4316-4F85-B814-1EE3DBC57C29

P921

Q27644544-FED3E8BA-B9A4-48DC-AD86-D136C951C823

P932

Q27644544-7EAD70DA-0538-46EA-9709-6A45899441DD

P3181

P356

J.CELL.2016.06.043

P1433

P1476

Vaccine-Induced Antibodies that Neutralize Group 1 and Group 2 Influenza A Viruses

@en

P2093

Adrian B McDermott

http://www.w3.org/2001/XMLSchema#string

Aliaksandr Druz

http://www.w3.org/2001/XMLSchema#string

Amy Ransier

http://www.w3.org/2001/XMLSchema#string

Baoshan Zhang

http://www.w3.org/2001/XMLSchema#string

Celia Santos

http://www.w3.org/2001/XMLSchema#string

Chen-Hsiang Shen

http://www.w3.org/2001/XMLSchema#string

Christopher R Lees

http://www.w3.org/2001/XMLSchema#string

Daniel C Douek

http://www.w3.org/2001/XMLSchema#string

Eun Sung Yang

http://www.w3.org/2001/XMLSchema#string

Gwo-Yu Chuang

http://www.w3.org/2001/XMLSchema#string

P2860

An integrated map of genetic variation from 1,092 human genomes

A highly conserved neutralizing epitope on group 2 influenza A viruses

Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses

Antibody recognition of a highly conserved influenza virus epitope

H7N9 avian influenza A virus and the perpetual challenge of potential human pandemicity

Structural basis of tyrosine sulfation and VH-gene usage in antibodies that recognize the HIV type 1 coreceptor-binding site on gp120

Structures of HIV-1 Env V1V2 with broadly neutralizing antibodies reveal commonalities that enable vaccine design

A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutinins

Highly Conserved Protective Epitopes on Influenza B Viruses

Broadly neutralizing human antibody that recognizes the receptor-binding pocket of influenza virus hemagglutinin

P304

609-23

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

3539643

http://www.w3.org/2001/XMLSchema#string

P356

10.1016/J.CELL.2016.06.043

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

166

http://www.w3.org/2001/XMLSchema#string

P50

Julie Ledgerwood

Lawrence Shapiro

Adam K Wheatley

Mangaiarkarasi Asokan

Masaru Kanekiyo

James C Mullikin

Barney S. Graham

P577

2016-07-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27453470

http://www.w3.org/2001/XMLSchema#string

P921

P932

4978566

http://www.w3.org/2001/XMLSchema#string